Kamlesh Sheth

Kamlesh Sheth is an experienced professional in drug substance development and manufacturing, currently serving as the Director of Drug Substance Development at Stemline Therapeutics, Inc. since October 2021. Prior to this role, Kamlesh held multiple positions at Amicus Therapeutics, including Associate Director of Drug Substance Development and Technical Operations, where responsibilities included leading CMC development and GMP manufacturing, process and analytical development, and technology transfers. Additional experience includes roles as Senior Investigator at Amicus Therapeutics and Sr. Process Chemist at ChemoDynamics LLP and Rhodia Pharma Solution, focusing on scalable manufacturing processes and development of active pharmaceutical ingredients. Kamlesh's career began as an Investigator at Zynaxis Inc., where innovative drug delivery systems were designed, and includes postdoctoral research in liquid crystal polymers. Kamlesh earned a Ph.D. from The Maharaja Sayajirao University of Baroda, specializing in the synthesis of potential liquid crystal polymers.